NDC 80425-0273-01 - DICLOENAC SODIUM and MISOPROSTOL DR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0273
- Requested NDC
- 80425-0273-01
- Package NDCs from labels
- 80425-0273-1, 80425-0273-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-02-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DICLOENAC SODIUM and MISOPROSTOL DR - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-02-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0273-1 | DICLOENAC SODIUM and MISOPROSTOLDR | 60 in 1 BOTTLE | TABLET | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0273 | DICLOENAC SODIUM AND MISOPROSTOL DR (DICLOENAC SODIUM AND MISOPROSTOL) TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 1 package rows | 20240224_f4d8c198-63e1-3109-e053-2995a90acad9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0273-1 | EA - Each | 80425-0273 | 3eacc955-b88d-467e-9b61-60fb0611f428 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium | DICLOFENAC SODIUM | Lupin Pharmaceuticals, Inc. | 609c5344-9c97-4fa8-ad53-d0f622ce64ec | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Dr. Reddy's Laboratories Inc. | c88b2512-0255-658d-252a-c006275159b0 | 2025-10-28 | Warnings | QTG126297Q |
| Arthritis Pain | DICLOFENAC SODIUM TOPICAL GEL, 1% | Strategic Sourcing Services, LLC | 5de514ee-fd59-ef95-8dc3-16e34321572b | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Chain Drug Marketing Association INC | 625d21e8-0731-1157-30fe-9f9868ff8dc4 | 2025-10-28 | Warnings | QTG126297Q |
| Diclofenac Sodium Topical Gel 1% | DICLOFENAC SODIUM TOPICAL GEL, 1% | Walgreens Company | 40d0553b-a97a-1315-3fca-8ef38611505e | 2025-10-28 | Warnings | QTG126297Q |
| Arthritis Pain | DICLOFENAC SODIUM TOPICAL GEL, 1% | Discount Drug Mart, Inc. | ae1ebe9c-b1fa-6762-949e-cb83b33319a2 | 2025-10-28 | Warnings | QTG126297Q |
| Diclofenac Sodium Topical Gel 1% | DICLOFENAC SODIUM TOPICAL GEL, 1% | Kroger Company | 2081371d-436a-16fc-db80-ced6288f52bc | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | GERI-CARE PHARMACEUTICALS CORP | 91fc618a-edd0-5944-083f-c00075476f55 | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | GLENMARK PHARMACEUTICALS INC., USA | dab3ae60-0135-43b3-a1d0-8752720af82a | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 41da2e11-58c7-9622-e063-6394a90a9fdb | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC | PHOENIX RX LLC | 41dab520-5651-a4c5-e063-6394a90a2962 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Misoprostol | MISOPROSTOL | ANI Pharmaceuticals, Inc. | 21386aa1-dc51-41c9-8872-dec4c71ebb46 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | 0E43V0BB57 |
| Diclofenac Sodium | DICLOFENAC SODIUM | BluePoint Laboratories | feb1541a-de83-47dd-be03-c43376527318 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Encube Ethicals, Inc. | 6e8c45e1-8cd4-4ff7-a758-f9d2ed37e593 | 2025-10-01 | Warnings | QTG126297Q |
| ARTHRITIS PAIN RELIEVING | DICLOFENAC SODIUM | Walgreen Company | b1850a16-54f1-4210-abdf-26414da8b3d9 | 2025-09-29 | Warnings | QTG126297Q |
| FOSTER AND THRIVE ARTHRITIS PAIN | DICLOFENAC SODIUM | Strategic Sourcing Services LLC | f9f4e55f-ffad-4df7-9b3c-1e7c3a3723c1 | 2025-09-27 | Warnings | QTG126297Q |
| DG HEALTH ARTHRITIS PAIN | DICLOFENAC SODIUM | Dolgencorp Inc | 6479e4bb-0790-483e-bfe3-a54d549aa5d2 | 2025-09-15 | Warnings | QTG126297Q |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | BluePoint Laboratories | 9a22cb4b-e49a-4bd7-b235-47405c302658 | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | 1359105 857706 QTG126297Q 0E43V0BB57 |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 3e15c3db-5245-76fb-e063-6394a90a814e | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclona | LIDOCAINE 4.5%, DICLOFENAC 1% | Preferred Pharmaceuticals Inc. | 4cc1d80b-2435-404f-949f-bd207a863631 | 2025-09-05 | Warnings, Adverse reactions | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.